SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2510Preclinical data from Pieris' inhaled IL-4Ra antagonist, from ERS: >>tuck-9/18/2018
2509Bit's me!Miljenko Zuanic-9/14/2018
2508why so slow?Felix B-9/14/2018
2507Roche: roche.com and Sanofi (on Kevzara) way tooooo sloooowwwww....https://www.Miljenko Zuanic-9/13/2018
2506In line of ABBV Upad P2b 32 w AD update, finance.yahoo.com and REGN decision to Miljenko Zuanic-9/13/2018
2505PEG is in conjugation (serine residue) for proteins (small and large)/Abs.Miljenko Zuanic-9/11/2018
2504Who care! It is up to them. They have nice gain,...so they can sell at any time.Miljenko Zuanic-9/11/2018
2503I've heard of PEG but usually along with "formulations" rather thaFelix B-9/11/2018
2502No advantage with them holding it?Felix B-9/11/2018
2501For those who do not follow tweeter: twitter.com REGN new candidate in clinics,Miljenko Zuanic-9/11/2018
2500Poly-ethylene-glycol! or PEG! Problem is "protein" folding that can muMiljenko Zuanic-9/10/2018
2499Sanofi will sell continuously, with larger lots as price advance further (I hopeMiljenko Zuanic-9/10/2018
2498The rationale behind the timing of their sale?Felix B-9/10/2018
2497Interesting, this is the first I've heard of an polymer conjugated to Ab forFelix B-9/10/2018
2496Yes it is, and at 5 mg dose it is lover "molecular" dose than Eylea atMiljenko Zuanic-9/10/2018
2495950 kDa is the largest mol wt I've ever heard of for an intraocular compoundDewDiligence_on_SI-9/10/2018
2494<We believe thatKSI-301 can be a highly differentiated treatment with an imprMiljenko Zuanic-9/10/2018
2493Another attempts to develop VEGF-PDGR combo at Kodiac Sciences (KOD, KSI-301) asMiljenko Zuanic-9/10/2018
2492Early indication does this ( BGB-A317 ) anti-Pd-1 Abs has chance as "secondMiljenko Zuanic-9/5/2018
2491ADVM-022 is not part of collaboration, but I am sure...if candidate show promiseMiljenko Zuanic18/30/2018
2490They are Avalanche right? THey are collaborating with REGN adverum.comFelix B-8/30/2018
2489Interesting how will REGN legal machinery react on this: finance.yahoo.comMiljenko Zuanic-8/29/2018
2488I also do not have subscription! It is about safety issue at compounding facilitMiljenko Zuanic-8/29/2018
2487What does the article say? I don't have a subscription.Felix B-8/29/2018
2486Downturn did not last long. CMS is ever-lasting -problem for Eylea, ....still coMiljenko Zuanic-8/29/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News